“…The EP prevalence was higher than in Spain in countries such as Colombia (≥90%) [98], Brazil 78.8% and 65.7% for T. equi and B. caballi , respectively, [44] or 97.5% for EP [100] and Mongolia with 82.3% EP seroprevalence [16], or 78.8% for T. equi and 65.7% for B. caballi , respectively [84]. However, it was lower in countries such as the UAE (33.3%) [48], Sudan (25.2%) [85], Portugal (17.9% and 11.1% for T. equi and B. caballi , respectively) [80], Turkey (18.4–18.5%) [51, 90], Jordan (14.6%) [2], Greece (11.6%) [56], Saudi Arabia (10.4% and 7.5% for T. equi and B. caballi , respectively) [6], Italy (8.5%) [40], Switzerland (7.3%) [92], the Netherlands (4%) [19] and Korea (1.1%) [87]. In other studies, the T. equi seroprevalence was higher than that described in Spain, but the seropositivity for B. caballi was lower, this is the case for France (from 58% to 80% for T. equi and from 1.2% to 12.9% for B. caballi ) [33, 38] and Iran (48% and 2%) [1].…”